South & Central America Parenteral Nutrition Market Forecast to 2030

At 6.5% CAGR, South & Central America Parenteral Nutrition Market is Speculated to be Worth US$ 597.42 Million by 2030, says the Research Team

According to the Research Team’ research, the South & Central America parenteral nutrition market was valued at US$ 360.63 million in 2022 and is expected to reach US$ 597.42 million by 2030, registering a CAGR of 6.5% from 2022 to 2030. Innovation in formulations of nutrition products and innovation in formulations of nutrition products are among the critical factors attributed to the South & Central America parenteral nutrition market expansion.

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macronutrient and micronutrient formulations of parenteral nutrition and their applications vary based on the type of disease, including cancer and gastrointestinal diseases.

Significant developments in Innovative formulations bring in a new era of nutritional solutions that are designed to meet all individual demands as well as the medical conditions of each patient. This level of personalization improves patient outcomes in addition to increasing the effectiveness of parenteral nutrition. Formulation innovations enable the market to fully meet the unique nutritional needs of different patients, from newborns and older adults to people with certain medical conditions. For example, the emergence of lipid-based emulsions with improved stability and bioavailability is changing the face of intravenous nourishment, especially for the treatment of premature infants. Additionally, the inherent risks of problems and side effects that have traditionally been connected to conventional nutritional solutions are reduced because of these formulation innovations. The industry is positioned for exceptional growth and long-term success because of its dual benefits of promoting the adoption of parenteral nutrition within the healthcare ecosystem and improving patient care. Thus, innovation in the formulations of nutrition products is anticipated to create opportunities for the market growth during the forecast period. Thus, the innovation in formulations of nutrition products act as future growth trends in the parenteral medical nutrition market.

On the contrary, mechanical, gastrointestinal, and metabolic complications associated with parenteral feeding systems hampers the growth of South & Central America parenteral nutrition market.

Based on nutrient type, the South & Central America parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held 33.2% market share in 2022, amassing US$ 119.73 million. It is projected to garner US$ 196.85 million by 2030 to register 6.4% CAGR during 2022-2030.

In terms of end user, the South & Central America parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held 59.7% share of South & Central America parenteral nutrition market in 2022, amassing US$ 215.17 million. It is projected to garner US$ 349.04 million by 2030 to expand at 6.2% CAGR during 2022-2030.

Based on country, the South & Central America parenteral nutrition market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 55.7% share of South & Central America parenteral nutrition market in 2022. It was assessed at US$ 211.59 million in 2022 and is likely to hit US$ 360.95 million by 2030, exhibiting a CAGR of 6.9% during 2022-2030.

Key players operating in the South & Central America parenteral nutrition market are ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America parenteral nutrition market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America parenteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America parenteral nutrition market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Parenteral Nutrition Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rise in Prevalence of Gastrointestinal Diseases
4.1.2 Surge in Cases of Malnutrition and Premature Births
4.2 Market Restraints
4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
4.3 Market Opportunities
4.3.1 Improved Healthcare Infrastructure in South & Central America
4.4 Future Trends
4.4.1 Innovation in Formulations of Nutrition Products
4.5 Impact Analysis
5. Parenteral Nutrition Market – South & Central America Market Analysis
5.1 Overview
5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 – 2030
6. South & Central America Parenteral Nutrition Market Analysis – by Nutrient Type
6.1 Overview
6.2 Single Dose Amino Acid Solution
6.2.1 Overview
6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Parenteral Lipid Emulsion
6.3.1 Overview
6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Carbohydrates
6.4.1 Overview
6.4.2 Carbohydrates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Trace Elements
6.5.1 Overview
6.5.2 Trace Elements: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Vitamins and Minerals
6.6.1 Overview
6.6.2 Vitamins and Minerals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Parenteral Nutrition Market Analysis – by End User
7.1 Overview
7.2 Hospitals
7.2.1 Overview
7.2.2 Hospitals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Clinics
7.3.1 Overview
7.3.2 Clinics: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Parenteral Nutrition Market – Country Analysis
8.1 South & Central America
8.1.1 South & Central America: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country
8.1.1.1 Brazil: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.1 Overview
8.1.1.1.2 Brazil: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.3 Brazil: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.1.4 Brazil: Parenteral Nutrition Market Breakdown, by End User
8.1.1.2 Argentina: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.1 Overview
8.1.1.2.2 Argentina: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.3 Argentina: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.2.4 Argentina: Parenteral Nutrition Market Breakdown, by End User
8.1.1.3 Rest of South & Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.1 Overview
8.1.1.3.2 Rest of South & Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.3 Rest of South & Central America: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.3.4 Rest of South & Central America: Parenteral Nutrition Market Breakdown, by End User
9. Industry Landscape
9.1 Overview
9.1.1 Overview
10. Company Profiles
10.1 ICU Medical Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Grifols SA
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Pfizer Inc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Otsuka Pharmaceuticals Co Ltd
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Baxter International Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 B Braun SE
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Fresenius Kabi AG
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Vifor Pharma Management AG
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Aculife Healthcare Pvt Ltd
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
11. Appendix
11.1 About The the Reporting Teams
11.2 Glossary of Terms

LIST OF TABLES

Table 1. Parenteral Nutrition Market Segmentation
Table 2. Brazil: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 3. Brazil: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 4. Argentina: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 5. Argentina: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 6. Rest of South & Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 7. Rest of South & Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 8. Recent Organic Growth Strategies in the Parenteral Nutrition Market
Table 9. Glossary of Terms, Parenteral Nutrition Market

LIST OF FIGURES

Figure 1. Parenteral Nutrition Market Segmentation, By Country
Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Parenteral Nutrition Market Share (%) – by Nutrient Type (2022 and 2030)
Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Carbohydrates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Trace Elements: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamins and Minerals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral Nutrition Market Share (%) – by End User (2022 and 2030)
Figure 12. Hospitals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinics: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. South & Central America: Parenteral Nutrition Market, By Key Country – Revenue (2022) (US$ Million)
Figure 16. South & Central America: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 17. Brazil: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)
Figure 18. Argentina: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)
Figure 19. Rest of South & Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)